Ticker
AVTXCompany Name
AVALO THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Issuance (Repayment) of Debt Securities | Net Cash Flow - Dividends & Other Cash Distributions | Shareholder Yield |
---|---|---|---|---|---|
6/30/2025 | $ 109.82M | $ 69.48M | $ 0 | $ 0 | -63.27% |
3/31/2025 | $ 43.31M | $ 69.44M | $ 0 | $ 0 | -160.34% |
12/31/2024 | $ 87.72M | $ 185.07M | $ 0 | $ 0 | -210.97% |
9/30/2024 | $ 134.19M | $ 115.63M | $ 0 | $ 0 | -86.17% |
6/30/2024 | $ 10.24M | $ 141.56M | $ -15.24M | $ 0 | -1233.86% |
3/31/2024 | $ 11.19M | $ 148.16M | $ -21.24M | $ 0 | -1134.29% |
12/31/2023 | $ 22.49M | $ 46.29M | $ -21.24M | $ 0 | -111.34% |
9/30/2023 | $ 18.85M | $ 46.37M | $ -21.24M | $ 0 | -133.25% |
6/30/2023 | $ 4.01M | $ 20.43M | $ -6M | $ 0 | -360.22% |
3/31/2023 | $ 37.23M | $ 13.86M | $ -14.81M | $ 0 | 2.55% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield
Shareholder Yield for AVALO THERAPEUTICS INC is calculated as follows: (-1 * CF - Equity [ $ 45.31M ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ -183.11K ]) / Market Cap [ $ 154.31M ]
(=) Shareholder Yield [ -29.24% ]
Minimum
Jun 30, 2024
Maximum
Dec 31, 2022
Average
Median
filtered constituents | 3.48K |
---|---|
min | -33.43% |
max | 34.45% |
average | 0.58% |
median | 1.07% |
std | 11.13% |